Non-small cell lung cancer

• Long-Term Results of Stereotactic Radiotherapy in Patients with at Least 10 Brain Metastases at Diagnosis
• Osimertinib Versus Durvalumab Versus Observation After Chemoradiation in Unresectable EGFR-Mutant NSCLC
• Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysiss
• Advancements and trends in exosome research in lung cancer from a bibliometric analysis (2004-2023)
• Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS Metastases
• Prognostic utility of blood inflammation biomarkers before and after treatment on the survival of patients with locally advanced non-small cell lung cancer undergoing stereotactic body radiotherapy
• Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung Cancer
• Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer

Non-small-cell lung cancer (NSCLC) is any type of epithelial lung cancer other than Small-cell lung cancer (SCLC).

Includes: adenocarcinoma (the most common NSCLC), large cell, squamous cell, bronchoalveolar.

Lung cancer continues to be a leading cause of cancer-related death worldwide, with non-Small-cell lung cancer (NSCLC) accounting for more than 80% of lung cancer cases.

Lung cancer is the leading cause of cancer mortality worldwide, accounting for 1.38 million annual deaths, representing 18.2% of total deaths from cancer ¹⁾.

Non-Small-cell lung cancer (NSCLC) account for more than 80% of lung cancer cases.

Among those, approximately 7.4% of non-Small-cell lung cancer (NSCLC) patients will have brain metastases (BM) at presentation ²⁾ , and between 20–40% of Non-Small-cell lung cancer (NSCLC) patients will develop intracranial metastases ^{3) 4)}.

see Non-Small-cell lung cancer classification.

Non-Small-cell lung cancer Diagnosis.

Non-Small cell lung cancer metastases

see Non-Small cell lung cancer treatment.

see Non-Small cell lung cancer outcome.

Non-Small-cell lung cancer case series.